These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia. Mesa RA, Elliott MA, Tefferi A. Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148 [Abstract] [Full Text] [Related]
3. Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases. Brenner B, Nagler A, Tatarsky I, Hashmonai M. Arch Intern Med; 1988 Nov; 148(11):2501-5. PubMed ID: 3190384 [Abstract] [Full Text] [Related]
13. Splenectomy for thrombocytopenia due to secondary hypersplenism. Coon WW. Arch Surg; 1988 Mar; 123(3):369-71. PubMed ID: 3422554 [Abstract] [Full Text] [Related]
14. Risks and benefits of splenectomy in myelofibrosis: an analysis of 39 cases. Lafaye F, Rain JD, Clot P, Najean Y. Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):359-62. PubMed ID: 7892130 [Abstract] [Full Text] [Related]
15. Palliative splenectomy in myelofibrosis with myeloid metaplasia. Mesa RA, Tefferi A. Leuk Lymphoma; 2001 Oct; 42(5):901-11. PubMed ID: 11697645 [Abstract] [Full Text] [Related]
16. Treatment of agnogenic myeloid metaplasia with danazol: a report of four cases. Lévy V, Bourgarit A, Delmer A, Legrand O, Baudard M, Rio B, Zittoun R. Am J Hematol; 1996 Dec; 53(4):239-41. PubMed ID: 8948661 [Abstract] [Full Text] [Related]